156 related articles for article (PubMed ID: 35394144)
21. Clinical and technical considerations for mediastinal Hodgkin lymphoma protontherapy based on a single-center early experience.
Loap P; Goudjil F; Dendale R; Kirova Y
Cancer Radiother; 2021 Dec; 25(8):779-785. PubMed ID: 34275748
[TBL] [Abstract][Full Text] [Related]
22. Comparison of butterfly volumetric modulated arc therapy to full arc with or without deep inspiration breath hold for the treatment of mediastinal lymphoma.
Starke A; Bowden J; Lynn R; Hall K; Hudson K; Rato A; Aldridge E; Robb D; Steele P; Brady J; Mikhaeel NG
Radiother Oncol; 2018 Dec; 129(3):449-455. PubMed ID: 30245037
[TBL] [Abstract][Full Text] [Related]
23. Radiation therapy planning for early-stage Hodgkin lymphoma: experience of the International Lymphoma Radiation Oncology Group.
Maraldo MV; Dabaja BS; Filippi AR; Illidge T; Tsang R; Ricardi U; Petersen PM; Schut DA; Garcia J; Headley J; Parent A; Guibord B; Ragona R; Specht L
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):144-52. PubMed ID: 25670544
[TBL] [Abstract][Full Text] [Related]
24. Auto- versus human-driven plan in mediastinal Hodgkin lymphoma radiation treatment.
Clemente S; Oliviero C; Palma G; D'Avino V; Liuzzi R; Conson M; Pacelli R; Cella L
Radiat Oncol; 2018 Oct; 13(1):202. PubMed ID: 30340604
[TBL] [Abstract][Full Text] [Related]
25. Proton therapy in adjuvant treatment of gastric cancer: planning comparison with advanced x-ray therapy and feasibility report.
Dionisi F; Avery S; Lukens JN; Ding X; Kralik J; Kirk M; Roses RE; Amichetti M; Metz JM; Plastaras JP
Acta Oncol; 2014 Oct; 53(10):1312-20. PubMed ID: 24797885
[TBL] [Abstract][Full Text] [Related]
26. Patient selection for proton therapy using Normal Tissue Complication Probability with deep learning dose prediction for oropharyngeal cancer.
Huet-Dastarac M; Michiels S; Rivas ST; Ozan H; Sterpin E; Lee JA; Barragan-Montero A
Med Phys; 2023 Oct; 50(10):6201-6214. PubMed ID: 37140481
[TBL] [Abstract][Full Text] [Related]
27. Benchmarking of a treatment planning system for spot scanning proton therapy: comparison and analysis of robustness to setup errors of photon IMRT and proton SFUD treatment plans of base of skull meningioma.
Harding R; Trnková P; Weston SJ; Lilley J; Thompson CM; Short SC; Loughrey C; Cosgrove VP; Lomax AJ; Thwaites DI
Med Phys; 2014 Nov; 41(11):111710. PubMed ID: 25370624
[TBL] [Abstract][Full Text] [Related]
28. Spot-Scanning Proton Arc (SPArc) Therapy: The First Robust and Delivery-Efficient Spot-Scanning Proton Arc Therapy.
Ding X; Li X; Zhang JM; Kabolizadeh P; Stevens C; Yan D
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1107-1116. PubMed ID: 27869083
[TBL] [Abstract][Full Text] [Related]
29. A comprehensive dosimetric study of pancreatic cancer treatment using three-dimensional conformal radiation therapy (3DCRT), intensity-modulated radiation therapy (IMRT), volumetric-modulated radiation therapy (VMAT), and passive-scattering and modulated-scanning proton therapy (PT).
Ding X; Dionisi F; Tang S; Ingram M; Hung CY; Prionas E; Lichtenwalner P; Butterwick I; Zhai H; Yin L; Lin H; Kassaee A; Avery S
Med Dosim; 2014; 39(2):139-45. PubMed ID: 24661778
[TBL] [Abstract][Full Text] [Related]
30. Proton therapy for adults with mediastinal lymphomas: the International Lymphoma Radiation Oncology Group guidelines.
Dabaja BS; Hoppe BS; Plastaras JP; Newhauser W; Rosolova K; Flampouri S; Mohan R; Mikhaeel NG; Kirova Y; Specht L; Yahalom J
Blood; 2018 Oct; 132(16):1635-1646. PubMed ID: 30108066
[TBL] [Abstract][Full Text] [Related]
31. Improve the dosimetric outcome in bilateral head and neck cancer (HNC) treatment using spot-scanning proton arc (SPArc) therapy: a feasibility study.
Liu G; Li X; Qin A; Zheng W; Yan D; Zhang S; Stevens C; Kabolizadeh P; Ding X
Radiat Oncol; 2020 Jan; 15(1):21. PubMed ID: 32000817
[TBL] [Abstract][Full Text] [Related]
32. Minimizing late effects for patients with mediastinal Hodgkin lymphoma: deep inspiration breath-hold, IMRT, or both?
Aznar MC; Maraldo MV; Schut DA; Lundemann M; Brodin NP; Vogelius IR; Berthelsen AK; Specht L; Petersen PM
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):169-74. PubMed ID: 25754634
[TBL] [Abstract][Full Text] [Related]
33. Advantage of proton-radiotherapy for pediatric patients and adolescents with Hodgkin's disease.
Lautenschlaeger S; Iancu G; Flatten V; Baumann K; Thiemer M; Dumke C; Zink K; Hauswald H; Vordermark D; Mauz-Körholz C; Engenhart-Cabillic R; Eberle F
Radiat Oncol; 2019 Sep; 14(1):157. PubMed ID: 31477141
[TBL] [Abstract][Full Text] [Related]
34. Comparison of organ-at-risk sparing and plan robustness for spot-scanning proton therapy and volumetric modulated arc photon therapy in head-and-neck cancer.
Barten DL; Tol JP; Dahele M; Slotman BJ; Verbakel WF
Med Phys; 2015 Nov; 42(11):6589-98. PubMed ID: 26520750
[TBL] [Abstract][Full Text] [Related]
35. Volumetric modulated arc therapy versus intensity-modulated proton therapy in neoadjuvant irradiation of locally advanced oesophageal cancer.
Celik E; Baus W; Baues C; Schröder W; Clivio A; Fogliata A; Scorsetti M; Marnitz S; Cozzi L
Radiat Oncol; 2020 May; 15(1):120. PubMed ID: 32448296
[TBL] [Abstract][Full Text] [Related]
36. Comparison of passive-beam proton therapy, helical tomotherapy and 3D conformal radiation therapy in Hodgkin's lymphoma female patients receiving involved-field or involved site radiation therapy.
Horn S; Fournier-Bidoz N; Pernin V; Peurien D; Vaillant M; Dendale R; Fourquet A; Kirova YM
Cancer Radiother; 2016 Apr; 20(2):98-103. PubMed ID: 26992750
[TBL] [Abstract][Full Text] [Related]
37. Intensity modulated proton therapy (IMPT) - The future of IMRT for head and neck cancer.
Moreno AC; Frank SJ; Garden AS; Rosenthal DI; Fuller CD; Gunn GB; Reddy JP; Morrison WH; Williamson TD; Holliday EB; Phan J; Blanchard P
Oral Oncol; 2019 Jan; 88():66-74. PubMed ID: 30616799
[TBL] [Abstract][Full Text] [Related]
38. Fondazione Italiana Linfomi (FIL) expert consensus on the use of intensity-modulated and image-guided radiotherapy for Hodgkin's lymphoma involving the mediastinum.
Filippi AR; Meregalli S; DI Russo A; Levis M; Ciammella P; Buglione M; Guerini AE; De Marco G; De Sanctis V; Vagge S; Ricardi U; Simontacchi G;
Radiat Oncol; 2020 Mar; 15(1):62. PubMed ID: 32164700
[TBL] [Abstract][Full Text] [Related]
39. Life years lost attributable to late effects after radiotherapy for early stage Hodgkin lymphoma: The impact of proton therapy and/or deep inspiration breath hold.
Rechner LA; Maraldo MV; Vogelius IR; Zhu XR; Dabaja BS; Brodin NP; Petersen PM; Specht L; Aznar MC
Radiother Oncol; 2017 Oct; 125(1):41-47. PubMed ID: 28838605
[TBL] [Abstract][Full Text] [Related]
40. Radiotherapy for mediastinal lymphoma in breath hold using surface monitoring and nasal high flow oxygen: Clinical experiences and breath hold stability.
Canters R; Vaassen F; Lubken I; Cobben M; Murrer L; Peeters S; Berbee M; Ta B
Radiother Oncol; 2023 Jun; 183():109594. PubMed ID: 36870610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
